Report Details the Best Practices in Establishing a Clear Corporate Value Proposition
CHAPEL HILL, N.C., March 31, 2014 /PRNewswire/ – The first step in defining a corporate value proposition is clearly identifying how an organization’s products and/or services vary from their competitors- or what sets them apart. If a company cannot define a unique characteristic or benefit of their product, customers may default to the most basic option of differentiation – price. For the pharmaceutical industry, defining a clear corporate value proposition is absolutely essential, as playing the low-price game is a lose-lose proposition- even when they make sales.
Although establishing a positive corporate image is critical, the pharmaceutical industry is currently missing out on building corporate image. According to recent primary and secondary research conducted by benchmarking firm, Best Practices, LLC, no pharmaceutical company cracked the top 100 Social Brands list in 2010. Despite this, this does represent a great opportunity for pharmaceutical companies to begin considering how to best present their value proposition to consumers, advocacy groups and health care providers.
The report, “Best Practices in Building Your Corporate Value Proposition” outlines valuable insights and findings from primary and secondary research around the value of building a positive company brand. The study will help corporate leadership to understand the importance of a corporate brand.
Key study topical areas include:
- Understanding Corporate Value
- Johnson & Johnson Case Study: Origin On Trust
- G.E. Healthcare’s Healthymagination
- Eli Lilly Case Study On Social Responsibility
- Corporate Brand Planning Processes
- Why Focus On Customer Loyalty?
- Achieving The Corporate Value Proposition
